Investments
1Portfolio Exits
1Partners & Customers
2About American Brain Tumor Association
Founded in 1973, the American Brain Tumor Association is a non-profit organization dedicated to funding brain tumor research. The ABTA is a catalyst for research-based breakthroughs in the causes, diagnosis and treatment of brain tumors, and recognized as the leading resource in patient-centered brain tumor information, education and support.
Want to inform investors similar to American Brain Tumor Association about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest American Brain Tumor Association News
Feb 21, 2023
News provided by Share this article Share this article CHICAGO, Feb. 21, 2023 /PRNewswire/ -- The American Brain Tumor Association announced today the appointment of Ram Subramanian as Chair of the Board of Directors, and newly-elected Member Srisupen Andersen, CFA. Their terms began on January 1, 2023. Ram Subramanian, ABTA Chair, Board of Directors In his new role as Board Chair, Ram Subramanian is responsible for leading the ABTA's Board of Directors, which provides strategic governance for the organization. He will work closely with Ralph DeVitto, president and CEO of the ABTA, to enhance the organization's reputation as a leader in serving brain tumor patients and funding breakthrough brain tumor research. "As the ABTA approaches its 50th year of service to the brain tumor community, Ram's passion and vision will help advance our patient education and support services and accelerate our research program," DeVitto said. Subramanian has served on the ABTA Board of Directors since 2015 and is the Vice President and Chief Marketing Officer for the $70+ Billion Deposit Business at Discover Financial Services, headquartered in Riverwoods, Illinois. Impacted by the brain tumor diagnosis of close friends and family, Subramanian is dedicated to ensuring brain tumor families have access to information and support they need to navigate a brain tumor diagnosis. In addition, the ABTA is proud to welcome Srisupen Andersen as a newly elected Board Member. Srisupen Andersen, CFA, is a Credit Products Manager at PNC Financial Services, where she manages a portfolio of 125+ commercial lending relationships. Andersen is a seasoned credit risk manager with 20 years of experience overseeing diverse portfolios at leading financial institutions. Andersen is a steadfast supporter of brain tumor research and advancing the ABTA mission, as her nine-year-old daughter Louise was diagnosed with brain cancer in 2009 and passed away the following year. The 2023 American Brain Tumor Association Board of Directors: Ram Subramanian—Chair; Bob Kruchten—Vice Chair; Danny Monson—Treasurer; Mindee Plugues—Secretary; Carla Varner—Immediate Past Chair; and Members—Srisupen Andersen; Mitchel S. Berger, M.D. ; Jim Reilly and Patti Tsai-Steiner. President & CEO
American Brain Tumor Association Investments
1 Investments
American Brain Tumor Association has made 1 investments. Their latest investment was in Forte Biosciences as part of their Grant - III on May 5, 2011.
American Brain Tumor Association Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/10/2011 | Grant - III | Forte Biosciences | $0.2M | Yes | 1 |
Date | 5/10/2011 |
|---|---|
Round | Grant - III |
Company | Forte Biosciences |
Amount | $0.2M |
New? | Yes |
Co-Investors | |
Sources | 1 |
American Brain Tumor Association Portfolio Exits
1 Portfolio Exit
American Brain Tumor Association has 1 portfolio exit. Their latest portfolio exit was Forte Biosciences on April 13, 2017.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
4/13/2017 | IPO | Public | 1 |
Date | 4/13/2017 |
|---|---|
Exit | IPO |
Companies | |
Valuation | |
Acquirer | Public |
Sources | 1 |
American Brain Tumor Association Partners & Customers
2 Partners and customers
American Brain Tumor Association has 2 strategic partners and customers. American Brain Tumor Association recently partnered with National Cancer Institute on June 6, 2019.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
6/4/2019 | Partner | United States | The American Brain Tumor Association is partnering with the National Cancer Institute 's NCI-CONNECT initiative to advance the understanding of rare adult brain tumors and CNS cancers to improve approaches to care and treatment . | 2 | |
5/23/2008 | Partner |
Date | 6/4/2019 | 5/23/2008 |
|---|---|---|
Type | Partner | Partner |
Business Partner | ||
Country | United States | |
News Snippet | The American Brain Tumor Association is partnering with the National Cancer Institute 's NCI-CONNECT initiative to advance the understanding of rare adult brain tumors and CNS cancers to improve approaches to care and treatment . | |
Sources | 2 |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.